Cargando…
A retrospective cohort study of tamoxifen versus surgical treatment for ER-positive gynecomastia
BACKGROUND: Gynecomastia is a common condition in clinical practice. The present study aimed to review the clinical data of ER-positive gynecomastia patients treated by tamoxifen (TAM) versus surgery and discussed the clinical effects of the two treatment strategies. METHOD: We retrospectively colle...
Autores principales: | He, Weili, Wei, Weidong, Zhang, Qing, Lv, Rongzhao, Qu, Shaohua, Huang, Xin, Ma, Juan, Zhang, Ping, Zhai, Hening, Wang, Ningxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010038/ https://www.ncbi.nlm.nih.gov/pubmed/36915127 http://dx.doi.org/10.1186/s12902-023-01310-9 |
Ejemplares similares
-
FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
por: Lv, Qing, et al.
Publicado: (2021) -
Clinical and surgical management of unilateral prepubertal gynecomastia
por: Ferraro, Giuseppe Andrea, et al.
Publicado: (2014) -
Mixed gynecomastia
por: Qassabi, Salim S. Al, et al.
Publicado: (2015) -
Dynamic surveillance of tamoxifen‐resistance in ER‐positive breast cancer by CAIX‐targeted ultrasound imaging
por: Li, Ying, et al.
Publicado: (2020) -
Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer
por: Liu, Ying, et al.
Publicado: (2020)